(Q85965232)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

metastatic breast cancer

1 reference

1 reference

E Kontopodis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

N Kentepozidis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Ch Christophyllakis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

I Boukovinas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

A Kalykaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

K Kalbakis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

L Vamvakas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

S Agelaki

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

A Kotsakis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

N Vardakis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

V Georgoulias

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

D Mavroudis

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

15 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

22 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

153-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25398698%20AND%20SRC:MED&resulttype=core&format=json